INCLINE VILLAGE, Nev.,
April 26, 2017 /PRNewswire/ -- PDL
BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced
that the Company will release its first quarter 2017 financial
results for the period ended March 31,
2017, on Wednesday, May 3,
2017, after market close. PDL's management will host a
conference call and webcast that day at 4:30
p.m. Eastern Time to discuss the financial results. A slide
presentation relating to the call will be available via the webcast
link on the PDL website.
Conference Call Details
To access the live conference
call via phone, please dial (800) 668-4132 from the United States and Canada or (224) 357-2196 internationally. The
conference ID is 13017592. Please dial in approximately 10 minutes
prior to the start of the call. A telephone replay will be
available for one week following the call and may be accessed by
dialing (855) 859-2056 from the United
States and Canada or (404)
537-3406 internationally. The replay passcode is 13017592.
To access the live and subsequently archived webcast of the
conference call, go to the Company's website at http://www.pdl.com
and go to "Events & Presentations." Please connect to the
website at least 15 minutes prior to the call to allow for any
software download that may be necessary.
About PDL BioPharma
PDL seeks to provide a significant
return for its shareholders by acquiring and managing a portfolio
of companies, products, royalty agreements and debt facilities in
the biotech, pharmaceutical and medical device industries. In
late 2012, PDL began providing alternative sources of capital
through royalty monetizations and debt facilities and in 2016,
began making equity investments in commercial stage companies, the
first being Noden Pharma DAC. PDL has committed
over $1.4 billion and funded approximately $1.1
billion in these investments to date. PDL is
headquartered in Incline Village, Nevada.
For more information, please visit www.pdl.com.
PDL BioPharma and the PDL BioPharma logo are considered
trademarks of PDL BioPharma, Inc.
Contacts:
|
|
Peter
Garcia
|
Jennifer
Williams
|
PDL BioPharma,
Inc
|
Cook Williams
Communications, Inc
|
775-832-8500
|
360-668-3701
|
peter.garcia@pdl.com
|
jennifer@cwcomm.org
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/pdl-biopharma-to-announce-first-quarter-2017-financial-results-on-may-3-2017-300445397.html
SOURCE PDL BioPharma, Inc.